Healthscope Remains Firm Above $2.05

Healthscope has retested the $2.07 price gap and has seen strong buying support.

We see HSO as a good long-term value play with improving earnings over the next 2 – 5 years.

You’re not a member!  Trial today

Healthscope

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.